News

FemTech and Women’s Health start-ups urged to join Discovery Park’s growth programme, offering a support package worth over £50K


The Special Edition of the ‘Discovery Spark’ growth programme was announced at Kent & Medway Women’s Health Innovation Summit

Over 80 guests from across the biotech industry came to Stevenage Bioscience Catalyst to enjoy talks and networking with female leaders in celebration of International Women’s Day 2024 with the theme of ‘Inspire Inclusion.’

LEADING science companies and innovation parks will once again open their doors to showcase their contribution to sci-tech innovation when Cambridge Wide Open Day returns for 2024.


The event – organised annually by Hauxton-based life sciences and technology firm, o2h Group - offers a unique opportunity for ecosystem employers/ employees, sci-tech enthusiasts, and residents alike to explore Cambridge’s world-class science and technology facilities, and to meet the people behind the innovations, all in one day.

ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY

Biocair is calling for greater investment in women in STEM (science, technology, engineering and mathematics). The company believes these male-dominated sectors could benefit hugely from greater diversity.


Despite the rapid growth of the sector, women currently make up only 26% of the STEM workforce in the UK and just 28% in the USA. To combat this disparity, Biocair echoes the United Nation’s theme of International Women’s Day 2024: “Invest in women: Accelerate progress”.

Read eNews March here


Exciting Developments for our Network, featuring:


✅ Welcome from Tony Jones, CEO, One Nucleus


✅ Get your Boots on for Boston 2024!


✅ Who will be Crowned Best in Class? 


✅ And the Voting isn’t Over – Now it’s Your Turn?


✅ Save with us for these Two Global Events

AMSBIO has expanded its range of products and services dedicated to assisting scientists diversify their preclinical models effectively to help bridge the gender discrepancy gap in many areas of research.

Time-poor start-up founders need life science clusters to thrive


Mairi Dillion at Kadans


Trying to survive as a start-up can feel like an uphill battle. Finding investment, building partnerships, and reaching new audiences can be tricky on tight budgets and deadlines. And in the life sciences sector, this can prove even more challenging.

Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34m financing round. This significant financial milestone was achieved with the support of new investors Pioneer Group and 2048 Ventures, alongside existing backers Deep Science Ventures*, Cancer Research Horizons*, and Discovery Park Ventures. Additionally, the round received a non-dilutive grant award from UKRI’s Innovate UK Future Economy Investor Partnership Programme.

Pages